HEADER IMMUNE SYSTEM 16-JAN-19 6NOV TITLE A FAB DERIVED FROM IXEKIZUMAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: FAB HEAVY CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: FAB LIGHT CHAIN; COMPND 7 CHAIN: B, D; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS IL17, IL-17, IXEKIZUMAB, FAB, ANTIBODY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.D.DURBIN,D.K.CLAWSON,F.LU,Y.TIAN,J.LU,M.SCHMITT,S.ATWELL REVDAT 2 14-AUG-19 6NOV 1 JRNL REVDAT 1 19-JUN-19 6NOV 0 JRNL AUTH R.J.BENSCHOP,C.K.CHOW,Y.TIAN,J.NELSON,B.BARMETTLER,S.ATWELL, JRNL AUTH 2 D.CLAWSON,Q.CHAI,B.JONES,J.FITCHETT,S.TORGERSON,Y.JI,H.BINA, JRNL AUTH 3 N.HU,M.GHANEM,J.MANETTA,V.J.WROBLEWSKI,J.LU,B.W.ALLAN JRNL TITL DEVELOPMENT OF TIBULIZUMAB, A TETRAVALENT BISPECIFIC JRNL TITL 2 ANTIBODY TARGETING BAFF AND IL-17A FOR THE TREATMENT OF JRNL TITL 3 AUTOIMMUNE DISEASE. JRNL REF MABS V. 11 1175 2019 JRNL REFN ESSN 1942-0870 JRNL PMID 31181988 JRNL DOI 10.1080/19420862.2019.1624463 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.K.CHOW,B.W.ALLAN,Q.CHAI,S.ATWELL,J.LU REMARK 1 TITL THERAPEUTIC ANTIBODY ENGINEERING TO IMPROVE VISCOSITY AND REMARK 1 TITL 2 PHASE SEPARATION GUIDED BY CRYSTAL STRUCTURE. REMARK 1 REF MOL. PHARM. V. 13 915 2016 REMARK 1 REFN ESSN 1543-8392 REMARK 1 PMID 26849155 REMARK 1 DOI 10.1021/ACS.MOLPHARMACEUT.5B00817 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.87 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 58224 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 2822 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.15 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1165 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2953 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1113 REMARK 3 BIN R VALUE (WORKING SET) : 0.2919 REMARK 3 BIN FREE R VALUE : 0.3779 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.46 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 52 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6427 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 324 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.17630 REMARK 3 B22 (A**2) : 14.71650 REMARK 3 B33 (A**2) : -26.89280 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.390 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.245 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.204 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.239 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.204 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.872 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.842 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6657 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 9084 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2143 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1111 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6657 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 887 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7558 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.28 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.38 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NOV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JAN-19. REMARK 100 THE DEPOSITION ID IS D_1000239142. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225-HS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66339 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 41.688 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12700 REMARK 200 FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : 0.79300 REMARK 200 R SYM FOR SHELL (I) : 0.79300 REMARK 200 FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: 150UM PLATE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28% PEG 5000 MME/100 MM MES (PH REMARK 280 6.5)/200 MM AMMONIUM PHOSPHATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 59.20200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 98.74850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 59.20200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 98.74850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 133 REMARK 465 SER A 134 REMARK 465 LYS A 135 REMARK 465 SER A 136 REMARK 465 THR A 137 REMARK 465 SER A 138 REMARK 465 GLY A 139 REMARK 465 LYS A 220 REMARK 465 SER A 221 REMARK 465 CYS A 222 REMARK 465 ASP A 223 REMARK 465 LYS A 224 REMARK 465 THR A 225 REMARK 465 HIS A 226 REMARK 465 CYS B 219 REMARK 465 SER C 133 REMARK 465 SER C 134 REMARK 465 LYS C 135 REMARK 465 SER C 136 REMARK 465 THR C 137 REMARK 465 SER C 138 REMARK 465 GLY C 139 REMARK 465 LYS C 220 REMARK 465 SER C 221 REMARK 465 CYS C 222 REMARK 465 ASP C 223 REMARK 465 LYS C 224 REMARK 465 THR C 225 REMARK 465 HIS C 226 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 1 CG CD OE1 NE2 REMARK 470 GLU A 10 CG CD OE1 OE2 REMARK 470 LYS A 13 CG CD CE NZ REMARK 470 GLN A 43 CG CD OE1 NE2 REMARK 470 GLN A 62 CG CD OE1 NE2 REMARK 470 LYS A 65 CB CG CD CE NZ REMARK 470 GLU A 89 CG CD OE1 OE2 REMARK 470 SER A 121 CB OG REMARK 470 SER A 159 CB OG REMARK 470 ASN A 161 CG OD1 ND2 REMARK 470 SER A 162 OG REMARK 470 SER A 192 OG REMARK 470 SER A 194 OG REMARK 470 LEU A 195 CG CD1 CD2 REMARK 470 GLN A 198 CG CD OE1 NE2 REMARK 470 ILE A 201 CG1 CG2 CD1 REMARK 470 ASN A 203 CB CG OD1 ND2 REMARK 470 LYS A 212 CG CD CE NZ REMARK 470 ASP A 214 CB CG OD1 OD2 REMARK 470 LYS A 215 CE NZ REMARK 470 LYS A 216 CB CG CD CE NZ REMARK 470 GLU A 218 CD OE1 OE2 REMARK 470 ARG B 24 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 110 CG CD OE1 OE2 REMARK 470 PHE B 121 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 131 CG CD CE NZ REMARK 470 SER B 132 OG REMARK 470 ARG B 147 NE CZ NH1 NH2 REMARK 470 LYS B 188 CE NZ REMARK 470 GLN C 1 CG CD OE1 NE2 REMARK 470 GLN C 62 CG CD OE1 NE2 REMARK 470 ARG C 63 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 65 CG CD CE NZ REMARK 470 ARG C 87 CG CD NE CZ NH1 NH2 REMARK 470 LEU C 195 CG CD1 CD2 REMARK 470 THR C 197 OG1 CG2 REMARK 470 ILE C 201 CG1 CG2 CD1 REMARK 470 LYS C 216 CD CE NZ REMARK 470 GLU C 218 CB CG CD OE1 OE2 REMARK 470 ARG D 24 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 82 CG CD NE CZ NH1 NH2 REMARK 470 ASP D 127 CG OD1 OD2 REMARK 470 LYS D 150 CG CD CE NZ REMARK 470 LYS D 154 CG CD CE NZ REMARK 470 LYS D 174 CD CE NZ REMARK 470 LYS D 188 CE NZ REMARK 470 SER D 208 OG REMARK 470 GLU D 218 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 130 77.02 -114.27 REMARK 500 ASP A 150 72.54 45.84 REMARK 500 ASN A 161 62.10 61.09 REMARK 500 THR A 166 -23.35 -140.30 REMARK 500 TYR A 200 93.47 -67.51 REMARK 500 ASN A 210 28.52 49.79 REMARK 500 VAL B 56 -52.64 80.45 REMARK 500 ASN B 143 74.64 48.14 REMARK 500 LEU C 130 79.45 -113.38 REMARK 500 ASP C 150 72.17 54.26 REMARK 500 SER C 192 -6.66 -56.74 REMARK 500 LEU C 195 92.25 -62.16 REMARK 500 GLN C 198 -37.18 -143.05 REMARK 500 THR C 199 119.30 68.44 REMARK 500 VAL D 56 -53.78 84.33 REMARK 500 ASN D 143 74.09 49.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 12P A 301 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 12P A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6NOU RELATED DB: PDB REMARK 900 6NOU IS THE CORRESPONDING SCFV DBREF 6NOV A 1 226 PDB 6NOV 6NOV 1 226 DBREF 6NOV B 1 219 PDB 6NOV 6NOV 1 219 DBREF 6NOV C 1 226 PDB 6NOV 6NOV 1 226 DBREF 6NOV D 1 219 PDB 6NOV 6NOV 1 219 SEQRES 1 A 226 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 A 226 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 A 226 TYR SER PHE THR ASP TYR HIS ILE HIS TRP VAL ARG GLN SEQRES 4 A 226 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY VAL ILE ASN SEQRES 5 A 226 PRO MET TYR GLY THR THR ASP TYR ASN GLN ARG PHE LYS SEQRES 6 A 226 GLY ARG VAL THR ILE THR ALA ASP GLU SER THR SER THR SEQRES 7 A 226 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 A 226 ALA VAL TYR TYR CYS ALA ARG TYR ASP TYR PHE THR GLY SEQRES 9 A 226 THR GLY VAL TYR TRP GLY GLN GLY THR LEU VAL THR VAL SEQRES 10 A 226 SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU SEQRES 11 A 226 ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA SEQRES 12 A 226 LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL SEQRES 13 A 226 THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL SEQRES 14 A 226 HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SEQRES 15 A 226 SER LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU SEQRES 16 A 226 GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SEQRES 17 A 226 SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER SEQRES 18 A 226 CYS ASP LYS THR HIS SEQRES 1 B 219 ASP ILE VAL MET THR GLN THR PRO LEU SER LEU SER VAL SEQRES 2 B 219 THR PRO GLY GLN PRO ALA SER ILE SER CYS ARG SER SER SEQRES 3 B 219 ARG SER LEU VAL HIS SER ARG GLY ASN THR TYR LEU HIS SEQRES 4 B 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO GLN LEU LEU SEQRES 5 B 219 ILE TYR LYS VAL SER ASN ARG PHE ILE GLY VAL PRO ASP SEQRES 6 B 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 B 219 LYS ILE SER ARG VAL GLU ALA GLU ASP VAL GLY VAL TYR SEQRES 8 B 219 TYR CYS SER GLN SER THR HIS LEU PRO PHE THR PHE GLY SEQRES 9 B 219 GLN GLY THR LYS LEU GLU ILE LYS ARG THR VAL ALA ALA SEQRES 10 B 219 PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU SEQRES 11 B 219 LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 B 219 PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP SEQRES 13 B 219 ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR SEQRES 14 B 219 GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER SEQRES 15 B 219 THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS SEQRES 16 B 219 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 B 219 PRO VAL THR LYS SER PHE ASN ARG GLY GLU CYS SEQRES 1 C 226 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 C 226 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 C 226 TYR SER PHE THR ASP TYR HIS ILE HIS TRP VAL ARG GLN SEQRES 4 C 226 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY VAL ILE ASN SEQRES 5 C 226 PRO MET TYR GLY THR THR ASP TYR ASN GLN ARG PHE LYS SEQRES 6 C 226 GLY ARG VAL THR ILE THR ALA ASP GLU SER THR SER THR SEQRES 7 C 226 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 C 226 ALA VAL TYR TYR CYS ALA ARG TYR ASP TYR PHE THR GLY SEQRES 9 C 226 THR GLY VAL TYR TRP GLY GLN GLY THR LEU VAL THR VAL SEQRES 10 C 226 SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU SEQRES 11 C 226 ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA SEQRES 12 C 226 LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL SEQRES 13 C 226 THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL SEQRES 14 C 226 HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SEQRES 15 C 226 SER LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU SEQRES 16 C 226 GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SEQRES 17 C 226 SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER SEQRES 18 C 226 CYS ASP LYS THR HIS SEQRES 1 D 219 ASP ILE VAL MET THR GLN THR PRO LEU SER LEU SER VAL SEQRES 2 D 219 THR PRO GLY GLN PRO ALA SER ILE SER CYS ARG SER SER SEQRES 3 D 219 ARG SER LEU VAL HIS SER ARG GLY ASN THR TYR LEU HIS SEQRES 4 D 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO GLN LEU LEU SEQRES 5 D 219 ILE TYR LYS VAL SER ASN ARG PHE ILE GLY VAL PRO ASP SEQRES 6 D 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 D 219 LYS ILE SER ARG VAL GLU ALA GLU ASP VAL GLY VAL TYR SEQRES 8 D 219 TYR CYS SER GLN SER THR HIS LEU PRO PHE THR PHE GLY SEQRES 9 D 219 GLN GLY THR LYS LEU GLU ILE LYS ARG THR VAL ALA ALA SEQRES 10 D 219 PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU SEQRES 11 D 219 LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 D 219 PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP SEQRES 13 D 219 ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR SEQRES 14 D 219 GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER SEQRES 15 D 219 THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS SEQRES 16 D 219 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 D 219 PRO VAL THR LYS SER PHE ASN ARG GLY GLU CYS HET 12P A 301 30 HETNAM 12P DODECAETHYLENE GLYCOL HETSYN 12P POLYETHYLENE GLYCOL PEG400 FORMUL 5 12P C24 H50 O13 FORMUL 6 HOH *324(H2 O) HELIX 1 AA1 SER A 28 TYR A 32 5 5 HELIX 2 AA2 GLN A 62 LYS A 65 5 4 HELIX 3 AA3 ARG A 87 THR A 91 5 5 HELIX 4 AA4 SER A 193 GLN A 198 1 6 HELIX 5 AA5 LYS A 207 ASN A 210 5 4 HELIX 6 AA6 GLU B 84 VAL B 88 5 5 HELIX 7 AA7 SER B 126 LYS B 131 1 6 HELIX 8 AA8 LYS B 188 LYS B 193 1 6 HELIX 9 AA9 SER C 28 TYR C 32 5 5 HELIX 10 AB1 GLN C 62 LYS C 65 5 4 HELIX 11 AB2 ARG C 87 THR C 91 5 5 HELIX 12 AB3 SER C 162 ALA C 164 5 3 HELIX 13 AB4 LYS C 207 ASN C 210 5 4 HELIX 14 AB5 GLU D 84 VAL D 88 5 5 HELIX 15 AB6 SER D 126 LYS D 131 1 6 HELIX 16 AB7 LYS D 188 LYS D 193 1 6 SHEET 1 AA1 4 GLN A 3 GLN A 6 0 SHEET 2 AA1 4 VAL A 18 SER A 25 -1 O LYS A 23 N VAL A 5 SHEET 3 AA1 4 THR A 78 LEU A 83 -1 O MET A 81 N VAL A 20 SHEET 4 AA1 4 VAL A 68 ASP A 73 -1 N THR A 71 O TYR A 80 SHEET 1 AA2 6 GLU A 10 LYS A 12 0 SHEET 2 AA2 6 THR A 113 VAL A 117 1 O THR A 116 N LYS A 12 SHEET 3 AA2 6 ALA A 92 TYR A 99 -1 N TYR A 94 O THR A 113 SHEET 4 AA2 6 HIS A 33 GLN A 39 -1 N HIS A 35 O ALA A 97 SHEET 5 AA2 6 GLU A 46 ILE A 51 -1 O MET A 48 N TRP A 36 SHEET 6 AA2 6 THR A 58 TYR A 60 -1 O ASP A 59 N VAL A 50 SHEET 1 AA3 4 GLU A 10 LYS A 12 0 SHEET 2 AA3 4 THR A 113 VAL A 117 1 O THR A 116 N LYS A 12 SHEET 3 AA3 4 ALA A 92 TYR A 99 -1 N TYR A 94 O THR A 113 SHEET 4 AA3 4 GLY A 106 TRP A 109 -1 O TYR A 108 N ARG A 98 SHEET 1 AA4 4 SER A 126 LEU A 130 0 SHEET 2 AA4 4 LEU A 144 TYR A 151 -1 O LEU A 147 N PHE A 128 SHEET 3 AA4 4 TYR A 182 VAL A 188 -1 O LEU A 184 N VAL A 148 SHEET 4 AA4 4 VAL A 169 THR A 171 -1 N HIS A 170 O VAL A 187 SHEET 1 AA5 4 SER A 126 LEU A 130 0 SHEET 2 AA5 4 LEU A 144 TYR A 151 -1 O LEU A 147 N PHE A 128 SHEET 3 AA5 4 TYR A 182 VAL A 188 -1 O LEU A 184 N VAL A 148 SHEET 4 AA5 4 VAL A 175 LEU A 176 -1 N VAL A 175 O SER A 183 SHEET 1 AA6 3 THR A 157 TRP A 160 0 SHEET 2 AA6 3 ILE A 201 HIS A 206 -1 O ASN A 203 N SER A 159 SHEET 3 AA6 3 THR A 211 LYS A 216 -1 O VAL A 213 N VAL A 204 SHEET 1 AA7 4 MET B 4 THR B 7 0 SHEET 2 AA7 4 ALA B 19 SER B 25 -1 O ARG B 24 N THR B 5 SHEET 3 AA7 4 ASP B 75 ILE B 80 -1 O LEU B 78 N ILE B 21 SHEET 4 AA7 4 PHE B 67 SER B 72 -1 N SER B 68 O LYS B 79 SHEET 1 AA8 6 SER B 10 VAL B 13 0 SHEET 2 AA8 6 THR B 107 ILE B 111 1 O GLU B 110 N LEU B 11 SHEET 3 AA8 6 GLY B 89 GLN B 95 -1 N TYR B 91 O THR B 107 SHEET 4 AA8 6 LEU B 38 GLN B 43 -1 N HIS B 39 O SER B 94 SHEET 5 AA8 6 GLN B 50 TYR B 54 -1 O ILE B 53 N TRP B 40 SHEET 6 AA8 6 ASN B 58 ARG B 59 -1 O ASN B 58 N TYR B 54 SHEET 1 AA9 4 SER B 10 VAL B 13 0 SHEET 2 AA9 4 THR B 107 ILE B 111 1 O GLU B 110 N LEU B 11 SHEET 3 AA9 4 GLY B 89 GLN B 95 -1 N TYR B 91 O THR B 107 SHEET 4 AA9 4 THR B 102 PHE B 103 -1 O THR B 102 N GLN B 95 SHEET 1 AB1 2 VAL B 30 SER B 32 0 SHEET 2 AB1 2 ASN B 35 THR B 36 -1 O ASN B 35 N HIS B 31 SHEET 1 AB2 4 SER B 119 PHE B 123 0 SHEET 2 AB2 4 THR B 134 PHE B 144 -1 O LEU B 140 N PHE B 121 SHEET 3 AB2 4 TYR B 178 SER B 187 -1 O LEU B 184 N VAL B 137 SHEET 4 AB2 4 SER B 164 VAL B 168 -1 N GLN B 165 O THR B 183 SHEET 1 AB3 4 ALA B 158 LEU B 159 0 SHEET 2 AB3 4 LYS B 150 VAL B 155 -1 N VAL B 155 O ALA B 158 SHEET 3 AB3 4 VAL B 196 THR B 202 -1 O GLU B 200 N GLN B 152 SHEET 4 AB3 4 VAL B 210 ASN B 215 -1 O VAL B 210 N VAL B 201 SHEET 1 AB4 4 GLN C 3 GLN C 6 0 SHEET 2 AB4 4 VAL C 18 SER C 25 -1 O LYS C 23 N VAL C 5 SHEET 3 AB4 4 THR C 78 LEU C 83 -1 O MET C 81 N VAL C 20 SHEET 4 AB4 4 VAL C 68 ASP C 73 -1 N THR C 71 O TYR C 80 SHEET 1 AB5 6 GLU C 10 LYS C 12 0 SHEET 2 AB5 6 THR C 113 VAL C 117 1 O THR C 116 N LYS C 12 SHEET 3 AB5 6 ALA C 92 TYR C 99 -1 N TYR C 94 O THR C 113 SHEET 4 AB5 6 HIS C 33 GLN C 39 -1 N HIS C 35 O ALA C 97 SHEET 5 AB5 6 GLU C 46 ILE C 51 -1 O MET C 48 N TRP C 36 SHEET 6 AB5 6 THR C 58 TYR C 60 -1 O ASP C 59 N VAL C 50 SHEET 1 AB6 4 GLU C 10 LYS C 12 0 SHEET 2 AB6 4 THR C 113 VAL C 117 1 O THR C 116 N LYS C 12 SHEET 3 AB6 4 ALA C 92 TYR C 99 -1 N TYR C 94 O THR C 113 SHEET 4 AB6 4 GLY C 106 TRP C 109 -1 O TYR C 108 N ARG C 98 SHEET 1 AB7 4 SER C 126 LEU C 130 0 SHEET 2 AB7 4 THR C 141 TYR C 151 -1 O GLY C 145 N LEU C 130 SHEET 3 AB7 4 TYR C 182 PRO C 191 -1 O LEU C 184 N VAL C 148 SHEET 4 AB7 4 VAL C 169 THR C 171 -1 N HIS C 170 O VAL C 187 SHEET 1 AB8 4 SER C 126 LEU C 130 0 SHEET 2 AB8 4 THR C 141 TYR C 151 -1 O GLY C 145 N LEU C 130 SHEET 3 AB8 4 TYR C 182 PRO C 191 -1 O LEU C 184 N VAL C 148 SHEET 4 AB8 4 VAL C 175 LEU C 176 -1 N VAL C 175 O SER C 183 SHEET 1 AB9 3 THR C 157 TRP C 160 0 SHEET 2 AB9 3 TYR C 200 HIS C 206 -1 O ASN C 203 N SER C 159 SHEET 3 AB9 3 THR C 211 VAL C 217 -1 O VAL C 217 N TYR C 200 SHEET 1 AC1 4 MET D 4 THR D 7 0 SHEET 2 AC1 4 ALA D 19 SER D 25 -1 O ARG D 24 N THR D 5 SHEET 3 AC1 4 ASP D 75 ILE D 80 -1 O LEU D 78 N ILE D 21 SHEET 4 AC1 4 PHE D 67 SER D 72 -1 N SER D 68 O LYS D 79 SHEET 1 AC2 6 SER D 10 VAL D 13 0 SHEET 2 AC2 6 THR D 107 ILE D 111 1 O GLU D 110 N LEU D 11 SHEET 3 AC2 6 GLY D 89 GLN D 95 -1 N TYR D 91 O THR D 107 SHEET 4 AC2 6 LEU D 38 GLN D 43 -1 N HIS D 39 O SER D 94 SHEET 5 AC2 6 GLN D 50 TYR D 54 -1 O ILE D 53 N TRP D 40 SHEET 6 AC2 6 ASN D 58 ARG D 59 -1 O ASN D 58 N TYR D 54 SHEET 1 AC3 4 SER D 10 VAL D 13 0 SHEET 2 AC3 4 THR D 107 ILE D 111 1 O GLU D 110 N LEU D 11 SHEET 3 AC3 4 GLY D 89 GLN D 95 -1 N TYR D 91 O THR D 107 SHEET 4 AC3 4 THR D 102 PHE D 103 -1 O THR D 102 N GLN D 95 SHEET 1 AC4 2 VAL D 30 SER D 32 0 SHEET 2 AC4 2 ASN D 35 THR D 36 -1 O ASN D 35 N HIS D 31 SHEET 1 AC5 4 SER D 119 PHE D 123 0 SHEET 2 AC5 4 THR D 134 PHE D 144 -1 O LEU D 140 N PHE D 121 SHEET 3 AC5 4 TYR D 178 SER D 187 -1 O LEU D 184 N VAL D 137 SHEET 4 AC5 4 SER D 164 VAL D 168 -1 N GLN D 165 O THR D 183 SHEET 1 AC6 4 ALA D 158 LEU D 159 0 SHEET 2 AC6 4 LYS D 150 VAL D 155 -1 N VAL D 155 O ALA D 158 SHEET 3 AC6 4 VAL D 196 THR D 202 -1 O GLU D 200 N GLN D 152 SHEET 4 AC6 4 VAL D 210 ASN D 215 -1 O VAL D 210 N VAL D 201 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.06 SSBOND 2 CYS A 146 CYS A 202 1555 1555 2.03 SSBOND 3 CYS B 23 CYS B 93 1555 1555 2.09 SSBOND 4 CYS B 139 CYS B 199 1555 1555 2.03 SSBOND 5 CYS C 22 CYS C 96 1555 1555 2.06 SSBOND 6 CYS C 146 CYS C 202 1555 1555 2.04 SSBOND 7 CYS D 23 CYS D 93 1555 1555 2.08 SSBOND 8 CYS D 139 CYS D 199 1555 1555 2.04 CISPEP 1 PHE A 152 PRO A 153 0 -1.34 CISPEP 2 GLU A 154 PRO A 155 0 9.41 CISPEP 3 THR B 7 PRO B 8 0 -6.35 CISPEP 4 LEU B 99 PRO B 100 0 -2.59 CISPEP 5 TYR B 145 PRO B 146 0 -2.78 CISPEP 6 PHE C 152 PRO C 153 0 -1.63 CISPEP 7 GLU C 154 PRO C 155 0 10.42 CISPEP 8 THR D 7 PRO D 8 0 -5.41 CISPEP 9 LEU D 99 PRO D 100 0 -4.19 CISPEP 10 TYR D 145 PRO D 146 0 1.07 SITE 1 AC1 12 ASP A 31 TYR A 32 HIS A 33 ASP A 100 SITE 2 AC1 12 TYR A 101 PHE A 102 HIS B 31 ASN B 35 SITE 3 AC1 12 TYR B 37 ASP C 31 TYR C 32 TYR C 101 CRYST1 118.404 197.497 44.540 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008446 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005063 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022452 0.00000